Enhancing Checkpoint Blockade in Lymphoma with In Situ Vaccination | Joshua Brody

Learn about a novel approach to improving checkpoint blockade therapy in cancer under investigation in early-phase trials by Joshua Brody, MD, and colleagues at the Icahn School of Medicine at Mount Sinai.

Embed